olmesartan has been researched along with Cardio-Renal Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirao, K; Mikawa, T; Mori, H; Nakajima, K; Niizuma, M; Ukai, H; Umemura, S; Yamamoto, H; Yuasa, S | 1 |
1 trial(s) available for olmesartan and Cardio-Renal Syndrome
Article | Year |
---|---|
Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study.
Topics: Aged; Albuminuria; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardio-Renal Syndrome; Circadian Rhythm; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2013 |